Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-17-002824
Filing Date
2017-01-18
Accepted
2017-01-18 17:02:00
Documents
1
Period of Report
2017-01-13

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4307
  Complete submission text file 0001104659-17-002824.txt   5783
Mailing Address 980 GREAT WEST ROAD BRENTFORD X0 TW9 9GS
Business Address
Rawcliffe Adrian (Reporting) CIK: 0001555851 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 17534010

Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)